| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
146,554 |
133,940 |
$11.56M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
128,399 |
116,898 |
$1.52M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,406 |
1,400 |
$808K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31,727 |
30,195 |
$557K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
40,801 |
38,538 |
$350K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,460 |
4,455 |
$215K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,452 |
5,441 |
$212K |
| 90750 |
|
1,136 |
1,135 |
$185K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,030 |
5,004 |
$178K |
| 59425 |
|
2,196 |
1,375 |
$165K |
| 90651 |
|
3,560 |
3,550 |
$134K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,265 |
3,250 |
$113K |
| 20610 |
|
3,437 |
2,245 |
$107K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,403 |
3,355 |
$106K |
| 90686 |
|
9,924 |
9,914 |
$94K |
| 92551 |
|
11,578 |
11,535 |
$91K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
647 |
645 |
$88K |
| 64615 |
|
981 |
978 |
$79K |
| 90715 |
|
2,983 |
2,975 |
$74K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,747 |
1,741 |
$72K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
2,930 |
2,747 |
$70K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
544 |
542 |
$68K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
833 |
831 |
$63K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
823 |
822 |
$61K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,239 |
2,211 |
$60K |
| 90670 |
|
3,407 |
3,363 |
$49K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
13,125 |
11,176 |
$43K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,935 |
1,735 |
$39K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
129 |
126 |
$36K |
| 90734 |
|
2,410 |
2,404 |
$26K |
| 99406 |
|
2,495 |
2,382 |
$26K |
| 90648 |
|
3,092 |
3,051 |
$23K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,548 |
5,505 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
1,019 |
1,016 |
$23K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
666 |
662 |
$22K |
| 99215 |
Prolong outpt/office vis |
220 |
220 |
$20K |
| 90633 |
|
2,150 |
2,129 |
$18K |
| 90620 |
|
508 |
506 |
$18K |
| 92250 |
|
317 |
317 |
$18K |
| 90710 |
|
1,800 |
1,790 |
$17K |
| 90723 |
|
2,102 |
2,064 |
$17K |
| 81002 |
|
11,568 |
10,068 |
$16K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,821 |
1,780 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,824 |
1,815 |
$14K |
| 0064A |
|
254 |
158 |
$13K |
| 82274 |
|
719 |
716 |
$13K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,519 |
1,479 |
$12K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
143 |
106 |
$12K |
| 90677 |
|
283 |
283 |
$12K |
| 90680 |
|
1,253 |
1,218 |
$11K |
| 0969 |
|
149 |
84 |
$11K |
| 73562 |
|
544 |
505 |
$11K |
| 81025 |
|
3,090 |
3,027 |
$10K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
794 |
762 |
$10K |
| J3490 |
Unclassified drugs |
506 |
502 |
$8K |
| 90739 |
|
102 |
102 |
$7K |
| 90682 |
|
148 |
148 |
$7K |
| 0012A |
|
130 |
68 |
$7K |
| 0071A |
|
129 |
80 |
$7K |
| 90662 |
|
299 |
298 |
$6K |
| 90700 |
|
692 |
682 |
$6K |
| 0072A |
|
110 |
57 |
$6K |
| 73630 |
|
290 |
256 |
$6K |
| 90696 |
|
627 |
626 |
$6K |
| H1003 |
Prenatal care, at-risk enhanced service; education |
183 |
151 |
$5K |
| 73610 |
|
213 |
201 |
$5K |
| 73030 |
|
216 |
197 |
$5K |
| 0054A |
|
81 |
50 |
$4K |
| 99173 |
|
5,134 |
5,129 |
$4K |
| 17110 |
|
33 |
25 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
61 |
58 |
$4K |
| 90837 |
Psychotherapy, 53 minutes with patient |
105 |
25 |
$4K |
| 90681 |
|
461 |
461 |
$4K |
| 90632 |
|
94 |
94 |
$4K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
123 |
123 |
$4K |
| 90732 |
|
43 |
43 |
$3K |
| 99442 |
|
195 |
190 |
$3K |
| 0011A |
|
59 |
32 |
$3K |
| 90678 |
|
13 |
13 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
438 |
340 |
$3K |
| 90716 |
|
92 |
90 |
$3K |
| 97802 |
|
36 |
35 |
$2K |
| 86580 |
|
690 |
672 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
366 |
354 |
$2K |
| 90688 |
|
126 |
126 |
$2K |
| 91322 |
|
69 |
69 |
$2K |
| 99383 |
|
36 |
36 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
320 |
319 |
$2K |
| 72110 |
|
54 |
54 |
$2K |
| 99188 |
|
79 |
79 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
31 |
12 |
$1K |
| 0004A |
|
25 |
14 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
103 |
103 |
$1K |
| 90697 |
|
169 |
169 |
$1K |
| 99384 |
|
17 |
17 |
$1K |
| 90707 |
|
59 |
58 |
$1K |
| 0124A |
|
15 |
15 |
$1K |
| 0134A |
|
14 |
14 |
$938.00 |
| 73110 |
|
40 |
37 |
$926.69 |
| 90480 |
|
32 |
32 |
$780.00 |
| 72100 |
|
29 |
29 |
$766.03 |
| 96127 |
|
199 |
199 |
$661.77 |
| 90685 |
|
52 |
52 |
$654.00 |
| 90746 |
|
14 |
13 |
$623.00 |
| 99441 |
|
42 |
42 |
$477.84 |
| 72050 |
|
13 |
13 |
$423.40 |
| 73502 |
|
12 |
12 |
$411.12 |
| 82948 |
|
322 |
310 |
$353.53 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
42 |
37 |
$310.89 |
| 73140 |
|
25 |
25 |
$305.58 |
| 99201 |
|
108 |
108 |
$281.05 |
| 85018 |
|
132 |
131 |
$261.17 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
15 |
15 |
$155.40 |
| 69209 |
|
13 |
13 |
$144.33 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
348 |
348 |
$135.90 |
| A4649 |
Surgical supply; miscellaneous |
49 |
49 |
$82.94 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
96 |
91 |
$82.82 |
| Z1034 |
|
1,623 |
1,201 |
$0.00 |
| 90656 |
|
337 |
337 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
12 |
12 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
20 |
12 |
$0.00 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
15 |
15 |
$0.00 |
| 0636 |
|
14 |
12 |
$0.00 |
| Z6400 |
|
15 |
15 |
$0.00 |